investment | GenomeWeb


Investors in Theranos may lose out and some are filing lawsuits, the Wall Street Journal reports.

UgenTec will use the funds to develop new features for its FastFinder software that will be released next year, as well to expand its sales efforts.

ImmunArray will use Quanterix's Simoa single-molecule array technology for biomarker analysis, with the potential to enrich its diagnostic panels.

The genomic data startup company said it will use the funds to market and sell its clinical software products around the world.

The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.

The startup, which was founded in 2015 by former BGI employees, is developing next-generation sequencing tests for cancer applications. 

William Bains at the Trade Secrets blog examines the behavior of biotech investors in different parts of the world.

N-of-One will use the funds to develop new oncology clinical decision support solutions, and to expand its sales and marketing efforts.

The company said the funding round raised nearly $140 million overall.

The investment, which will be paid out over the course of five years, comes in part from industry sources.


In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.